A positive correlation between SIAH2 and FOXP3 (Tregs marker) expression suggests that findings derived from a genetic murine melanoma model are relevant to human tumors and that low Siah2 levels could serve as a marker to stratify patients for ICT therapy. This evidence concerns the gene FOXP3 and melanoma.